Cite
Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults
MLA
Treanor, John J., et al. “Safety and Immunogenicity of a Recombinant Hemagglutinin Influenza–flagellin Fusion Vaccine (VAX125) in Healthy Young Adults.” Vaccine, vol. 28, no. 52, Dec. 2010, pp. 8268–74. EBSCOhost, https://doi.org/10.1016/j.vaccine.2010.10.009.
APA
Treanor, J. J., Taylor, D. N., Tussey, L., Hay, C., Nolan, C., Fitzgerald, T., Liu, G., Kavita, U., Song, L., Dark, I., & Shaw, A. (2010). Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine, 28(52), 8268–8274. https://doi.org/10.1016/j.vaccine.2010.10.009
Chicago
Treanor, John J., David N. Taylor, Lynda Tussey, Christine Hay, Carrie Nolan, Theresa Fitzgerald, Ge Liu, et al. 2010. “Safety and Immunogenicity of a Recombinant Hemagglutinin Influenza–flagellin Fusion Vaccine (VAX125) in Healthy Young Adults.” Vaccine 28 (52): 8268–74. doi:10.1016/j.vaccine.2010.10.009.